Nordic Mining

GoldHaven Resources Corp. is a Canadian junior metals exploration Company focused on acquiring and exploring highly prospective land packages in North America.

A Canadian uranium exploration firm, Standard Uranium (TSXV: STND), is concentrated on the Southwest Athabasca Uranium District's Davidson River flagship project.

Empress (TSXV: EMPR | OTCQB: EMPYF) is focussing on finding partners with development and production stage projects that require extra non-dilutive capital in order to construct a portfolio of investment opportunities in precious metal mining companies.

With over $8 million in cash on hand, ATAC Resources Ltd., a well-capitalized exploration company with a focus on the Yukon and Nevada, is situated in Vancouver. A positive Preliminary Economic Assessment for the Tiger Gold Deposit (PEA Pre-Tax NPV of $1182M and IRR of 545%) and an Inferred Resource of 1,685,000 ounces of gold at 423 g/t (in 124 Mt) for the Osiris Project are the results of work in Yukon.

MPCC acquires and operates Feeder container vessels between 1,000 and 3,000 TEU. These vessels are essential for the growing intra-regional trade. Second-hand Feeder vessels are trading near all-time lows and at large discounts to newbuild parity prices. This has enabled MPCC to create a sizeable fleet at attractive prices with some of the lowest cash operating costs in the industry.

Zelluna Immunotherapy AS is a privately owned Norwegian biopharmaceutical company founded in 2016 focused on the development of TCR based immunotherapies. Our goal is to revolutionize cancer therapy by developing TCR based therapies with the potential to treat a wide range of cancer types and patients. Zelluna’s core asset is a wide range of TCRs isolated from patients who exhibited long-term survival following inclusion in peptide based cancer vaccine trials initiated by Prof Gustav Gaudernack and conducted by investigators at the Norwegian Radium Hospital/Oslo University Hospital. Currently the company has several TCRs in different stages of development. We are a member of Oslo Cancer Cluster (Norwegian Centre of Expertise), a member organization for Norwegian and International stakeholders within cancer research and development. Oslo Cancer Cluster has members from the biotechnology industry, the government, patient organizations, research institutions and hospitals. Zelluna is located at the Oslo Cancer Cluster Innovation Park, next to the Norwegian Radium Hospital/Oslo University Hospital, the Department for Cellular Therapy and one of Europe’s largest academic certified GMP facilities for cellular products.

Hofseth BioCare's key goal is to offer high benefit added biomarine elements for human applications. Through inventive creation innovation and coordinated factors, they safeguard the nature of protein, calcium and oil extricated from fish. This innovation is exclusive to their organization.

Norwegian Property is a commercial property company that offers property development and property management services. Additionally, they provide financial and transaction solutions.

Maritime Robotics is a leading provider of cutting-edge unmanned solutions for maritime operations in challenging environments. They work closely with civilian, governmental, and military partners to develop technology that is high-quality, cost-effective, and reduces risks. Their systems can operate both in the air and on the surface, collecting a wide range of data from the atmosphere to the ocean floor. Maritime Robotics believes that the future of maritime operations will increasingly involve unmanned data gathering, setting new industry standards and expanding operational capabilities. Based in Trondheim, Norway, their team of skilled engineers and staff is ready to provide information, resources, and assistance to help clients find the best solution for their maritime needs.

Circio Holding ASA is a company in the clinical stage that is developing immune activators for challenging diseases. Their goal is to use vector-based technology to create a new type of circRNA medicines. They are working with Prof Michael Uhlin and his team at the Karolinska Institutet in Stockholm to develop advanced RNA therapeutics. Additionally, the company is conducting two collaborative clinical trials for a mutant RAS cancer vaccine program in the USA and Norway. They are also exploring financing options for a phase 2 study of ONCOS-102, a genetically modified oncolytic adenovirus.

Magnora Data Center is a developer and operator of data center infrastructure. The company focuses on specific facilities with energy capacities ranging between 20 and 150 megawatts. The firm advances these projects from the initial greenfield stage directly to the ready-to-build phase. The organization provides physical computing environments to support artificial intelligence workloads and standard data processing requirements.

PolarDC Group is an operator of HPC data center facilities, providing a full-service offer from design to first implementation and continuing operations, and prioritizing sustainability.